2014
DOI: 10.1016/j.cmet.2014.11.006
|View full text |Cite
|
Sign up to set email alerts
|

A Parabrachial-Hypothalamic Cholecystokinin Neurocircuit Controls Counterregulatory Responses to Hypoglycemia

Abstract: SummaryHypoglycemia engenders an autonomically mediated counterregulatory (CR)-response that stimulates endogenous glucose production to maintain concentrations within an appropriate physiological range. Although the involvement of the brain in preserving normoglycemia has been established, the neurocircuitry underlying centrally mediated CR-responses remains unclear. Here we demonstrate that lateral parabrachial nucleus cholecystokinin (CCKLPBN) neurons are a population of glucose-sensing cells (glucose inhib… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
155
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 145 publications
(164 citation statements)
references
References 27 publications
(32 reference statements)
3
155
1
Order By: Relevance
“…These LPBN neurons express both leptin receptor and CCK, and, like photoactivation of VMN SF1 neurons, pharmacogenetic activation of LPBN LepRb CCK neurons raises blood glucose levels in association with increased secretion of glucagon and corticosterone. Conversely, inhibition of LPBN LepRb CCK neurons blunts the glycemic response to glucoprivation (9,10), an effect resembling the consequences of optogenetic silencing of VMN SF1 neurons during insulin-induced hypoglycemia in the current studies. Because these LPBN LepRb CCK neurons project to the dmVMN and cVMN and because the induction of CRRs after activation of PBN LepRb CCK neurons is attenuated by pharmacogenetic inhibition of VMN SF1 neurons (10), we hypothesized that the former neurons provide ascending, stimulatory input to the subset of VMN SF1 neurons that project to the aBNST.…”
Section: Discussionsupporting
confidence: 60%
See 2 more Smart Citations
“…These LPBN neurons express both leptin receptor and CCK, and, like photoactivation of VMN SF1 neurons, pharmacogenetic activation of LPBN LepRb CCK neurons raises blood glucose levels in association with increased secretion of glucagon and corticosterone. Conversely, inhibition of LPBN LepRb CCK neurons blunts the glycemic response to glucoprivation (9,10), an effect resembling the consequences of optogenetic silencing of VMN SF1 neurons during insulin-induced hypoglycemia in the current studies. Because these LPBN LepRb CCK neurons project to the dmVMN and cVMN and because the induction of CRRs after activation of PBN LepRb CCK neurons is attenuated by pharmacogenetic inhibition of VMN SF1 neurons (10), we hypothesized that the former neurons provide ascending, stimulatory input to the subset of VMN SF1 neurons that project to the aBNST.…”
Section: Discussionsupporting
confidence: 60%
“…By comparison, few activated neurons were present in the ventrolateral (vl) portion of the VMN, an area associated with reproduction and aggressive behavior (32)(33)(34)(35). Together, these findings implicate subsets of SF1 neurons located in central and dorsomedial regions of the VMN in glycemic control (10).…”
Section: Identification Of Downstream Projections Of Vmn Sf1 Neuronsmentioning
confidence: 84%
See 1 more Smart Citation
“…Considering it together with the affinity of CCK receptors (600 pM for CCKAR; 300 pM for CCKBR) (Weiland et al, 2004), circulating CCK is unlikely to activate CCK receptors in the SFO. The CCK-expressing neurons were reportedly located in the parabrachial nucleus (Garfield et al, 2014) and nucleus tractus solitaries (D'Agostino et al, 2016), both of which were also known to be related to body fluid homeostasis (Johnson, 2007). Because neurons in these nuclei have projections to the SFO (McKinley et al, 2003), CCK originated from these neurons may contribute to the suppression of water neurons.…”
Section: Iv4 Discussionmentioning
confidence: 99%
“…Future studies are further warranted to better characterise and understand the neurons and neurocircuits that mediate the glucose-lowering and other neuroendocrine effects of leptin in uDM. To facilitate this, new advancements in neuroscience technologies, such as optogenetics and designer receptors exclusively activated by designer drugs (DREADDs), hold promise in the functional mapping and manipulation of discrete populations of cells involved in glycaemic control [54,55], similar to that which has been applied to increase our knowledge of feeding behaviour [56][57][58].…”
Section: Neurocircuitry Controlling Leptin's Glucose-lowering Effectsmentioning
confidence: 99%